Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry

被引:40
作者
Pina-Vaz, C
Costa-de-Oliveira, S
Rodrigues, AG
Espinel-Ingroff, A
机构
[1] Univ Porto, Dept Microbiol, Porto Sch Med, P-4200 Oporto, Portugal
[2] Univ Porto, Inst Pathol & Mol Immunol, P-4200 Oporto, Portugal
[3] Virginia Commonwealth Univ, Med Ctr, Richmond, VA 23298 USA
关键词
D O I
10.1128/JCM.43.9.4674-4679.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A cytometric approach to determine the susceptibilities of Candida spp. and Cryptococcus neoformans to voriconazole, itraconazole, and caspofungin is described. A total of 63 clinical isolates with different susceptibility patterns were exposed for 1, 2, 4, and 6 h to serial concentrations of each antifungal agent, followed by staining with two fluorescent probes: propidium iodide (PI) and FUN-1. FUN-1 was able to identify the susceptibility patterns of the assayed strains to the three agents after 1 It. PI penetrated a maximum of 50% of the cells treated with PI, at the highest concentration of caspofungin, 16 mu g/ml, after 6 h of incubation (this percentage varied with the strain and was drug concentration and time of incubation dependent) and did not stain cells treated with high concentrations of either azole after 6 h. The use of FUN-1 appears to be an excellent fast and reliable alternative to the classical dilution method for determining the susceptibility of Candida spp. and C. neoformans to these three antifungal agents.
引用
收藏
页码:4674 / 4679
页数:6
相关论文
共 23 条
[1]   In vitro activity of caspofungin against Candida albicans biofilms [J].
Bachmann, SP ;
VandeWalle, K ;
Ramage, G ;
Patterson, TF ;
Wickes, BL ;
Graybill, JR ;
López-Ribot, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3591-3596
[2]   Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans [J].
Chaturvedi, V ;
Ramani, R ;
Pfaller, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) :2249-2251
[3]  
Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080
[4]   Epidemiology of Candida species infections in critically ill non-immunosuppressed patients [J].
Eggimann, P ;
Garbino, J ;
Pittet, D .
LANCET INFECTIOUS DISEASES, 2003, 3 (11) :685-702
[5]   In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods [J].
Ernst, EJ ;
Klepser, ME ;
Ernst, ME ;
Messer, SA ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) :75-80
[6]   Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose [J].
EspinelIngroff, A ;
Pfaller, M ;
Erwin, ME ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :848-852
[7]   Epidemiology of nosocomial fungal infections [J].
Fridkin, SK ;
Jarvis, WR .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (04) :499-&
[8]   The role of antifungal susceptibility testing in the therapy of candidiasis [J].
Hospenthal, DR ;
Murray, CK ;
Rinaldi, MG .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 48 (03) :153-160
[9]   Rapid susceptibility testing of Candida albicans by flow cytometry [J].
Kirk, SM ;
Callister, SM ;
Lim, LCL ;
Schell, RF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (02) :358-363
[10]   Development of the FUN-1 family of fluorescent probes for vacuole labeling and viability testing of yeasts [J].
Millard, PJ ;
Roth, BL ;
Thi, HPT ;
Yue, ST ;
Haugland, RP .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1997, 63 (07) :2897-2905